Patents for A61K 49 - Preparations for testing in vivo (35,376) |
---|
01/29/2013 | US8361443 Peptide-based compounds |
01/29/2013 | US8361442 Oxime conjugates and methods for their formation and use |
01/29/2013 | US8361441 Detection and therapy of bacterial infection caused by Enterobacteriaceae |
01/29/2013 | US8361440 Imaging method and device for carrying out said method |
01/29/2013 | US8361438 N-alkoxyamide conjugates as imaging agents |
01/29/2013 | US8361437 Multimodal nanoparticles for non-invasive bio-imaging |
01/29/2013 | CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1 |
01/24/2013 | WO2013013067A2 Microbubble compositions, method of making same, and method using same |
01/24/2013 | WO2013013055A1 System for drug delivery and monitoring |
01/24/2013 | WO2013012754A1 Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same |
01/24/2013 | WO2013011984A1 Fluorescent probe and method for producing same |
01/24/2013 | US20130024955 Method for determining genotoxicity using non-fluorescent proteins |
01/24/2013 | US20130024953 Methods of Treating Disorders Associated with Protein Aggregation |
01/24/2013 | US20130023736 Systems for drug delivery and monitoring |
01/24/2013 | US20130023714 Medical and Imaging Nanoclusters |
01/24/2013 | US20130022990 Cellular labeling for nuclear magnetic resonance techniques |
01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
01/24/2013 | US20130022550 Microbubble Compositions, Method of Making Same, and Method Using Same |
01/24/2013 | US20130022549 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
01/24/2013 | US20130022548 Methods and Compositions Relating to Reporter Gels for Use in MRI Techniques |
01/24/2013 | US20130022547 Attenuated mycoplasma gallisepticum strains |
01/24/2013 | US20130022546 Peptides that Specifically Target Amyloid Deposits |
01/24/2013 | US20130022545 DRUG DELIVERY SYSTEM FOR TREATMENT OF LIVER CANCER BASED ON INTERVENTIONAL INJECTION OF TEMPERATURE AND pH-SENSITIVE HYDROGEL |
01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
01/24/2013 | US20130022543 Method for Treating and Confirming Diagnosis of Exertional Compartment Syndrome |
01/24/2013 | US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use |
01/24/2013 | DE102011108114A1 Device, useful for generating magnetic gradient fields having a field-free line, comprises an arrangement of electrical conductors extending on a cylinder jacket parallel to a cylinder axis, and an energization unit |
01/23/2013 | EP2548546A1 X-ray opaque infiltrant |
01/23/2013 | EP2547369A1 A nanoparticle comprising a micelle formed by an amphiphilic block- copolymer and encapsulating a gadolinium complex |
01/23/2013 | EP2547367A1 System for improved delivery of gene modulating compounds |
01/23/2013 | EP2547311A1 Kit and method for detecting porous dental hydroxy apatite |
01/23/2013 | CN102892434A Process for preparing hyperpolarized substrates and method for mri |
01/23/2013 | CN102892433A Staining composition |
01/23/2013 | CN102887833A Iodine-containing dimer contrast medium |
01/23/2013 | CN102887546A Water-soluble ferroferric oxide nano particle, preparation method and application thereof |
01/23/2013 | CN102886053A Composite nano capsule having ultrasonic/MRI (Magnetic Resonance Imaging) dual response and preparation method thereof |
01/23/2013 | CN102886048A Building method for medicament transportation or radiography carrier containing coat protein and inorganic nanoparticles |
01/23/2013 | CN102465117B Chimeric simian/human immunodeficency virus strain and application thereof |
01/23/2013 | CN102441180B Gastrointestinal B-ultrasonic developer |
01/23/2013 | CN102238908B Method for measuring physiological parameters in cerebral interstitial fluid and cerebral extracellular space |
01/23/2013 | CN101991867B Multi-mode targeted probe for early hepatic fibrosis diagnosis and preparation method thereof |
01/23/2013 | CN101954096B Multifunctional ultrasound contrast agent and preparation method thereof |
01/23/2013 | CN101854956B Imaging medium comprising hyperpolarised 13C-acetate and use thereof |
01/23/2013 | CN101378785B Compositions comprising magnetic iron oxide particles and use thereof in medical imaging |
01/22/2013 | US8357506 Method of identifying improved conjugates of biologically active compounds |
01/22/2013 | US8357351 Nano-scale contrast agents and methods of use |
01/22/2013 | CA2575677C Gas-filled microvesicles composition for contrast imaging |
01/22/2013 | CA2455638C Peptide-based multimeric targeted contrast agents |
01/22/2013 | CA2416307C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
01/17/2013 | WO2013010176A2 Pharmacophores for amyloid fibers involved in alzheimer's disease |
01/17/2013 | WO2013009701A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
01/17/2013 | WO2013009475A1 Photosensitizing antibody-phuorophore conjugates |
01/17/2013 | WO2012157900A3 18f-labeled precursor of pet radioactive medical supplies, and preparation method thereof |
01/17/2013 | WO2012136813A3 Agents for medical radar diagnosis |
01/17/2013 | US20130017155 Dual ct/mri nanoparticle contrast agent |
01/17/2013 | US20130017153 Unit dosage of apadenoson |
01/17/2013 | US20130017152 Method for the treatment of multiple sclerosis |
01/17/2013 | US20130017151 SUBSETS OF ANTIGEN-PRESENTING CELLS (APCs) IN THE HUMAN VAGINA AND THEIR DISTINCT FUNCTIONS |
01/17/2013 | US20130017148 Systems for producing multilayered particles, fibers and sprays and methods for administering the same |
01/17/2013 | US20130017147 Targeting agent for tumor site |
01/17/2013 | DE19941675B4 2-Amino-bicyclo[3.1.0] hexan-2,6-dicarbonsäurederivate und ein Verfahren zu deren Herstellung 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivatives and a process for their preparation |
01/17/2013 | CA2841120A1 Photosensitizing antibody-fluorophore conjugates |
01/16/2013 | EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
01/16/2013 | EP2545908A1 Medium for microbubbles or microparticles and preparation thereof |
01/16/2013 | EP2545085A1 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof |
01/16/2013 | EP2544723A2 Compositions for colon lavage and methods of making and using same |
01/16/2013 | CN102876328A Near-infrared fluorescent nanoparticle in-vivo probe and preparation method thereof |
01/16/2013 | CN102875647A Ligand polypeptide and medicine transferring system combined with specificity of CD40L protein |
01/16/2013 | CN102872463A Nanoparticles comprising rna ligands |
01/16/2013 | CN102871986A Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
01/16/2013 | CN101757643B Emulsion based on stabilizing agent, preparation method and application thereof |
01/10/2013 | WO2013006520A1 Compositions and methods for metabolic imaging |
01/10/2013 | WO2013004518A1 Ultrasonic couplant spray |
01/10/2013 | US20130012913 Injectable cross-linked hydrogels for biomaterial applications |
01/10/2013 | US20130011903 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities |
01/10/2013 | US20130011340 Compositions and methods comprising magnetic resonance contrast agents |
01/10/2013 | US20130011339 Nanoparticle compositions comprising a lipid bilayer and associated methods |
01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
01/10/2013 | US20130011337 Therapeutic agent and diagnostic agent for mitochondrial dysfunction brain diseases |
01/10/2013 | US20130011336 Imaging agents of fibrotic diseases |
01/10/2013 | US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery |
01/10/2013 | US20130011332 Frozen Compositions and Methods for Piercing a Substrate |
01/10/2013 | CA2840595A1 Compositions and methods for metabolic imaging |
01/09/2013 | EP2543666A1 Radioactive iodine labeled organic compound or salt thereof |
01/09/2013 | EP2542643A2 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same |
01/09/2013 | EP2542268A1 Solid composition for the oral administration of dyes and diagnostic use thereof |
01/09/2013 | EP2542264A1 Magnetic nanoparticles for cancer diagnostic and treatment purposes |
01/09/2013 | EP2542235A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
01/09/2013 | CN102863026A Water-dispersible manganese-doped magnetic nano-cluster, and preparation method and application thereof |
01/09/2013 | CN102861345A Preparation method of polymer microvesicle ultrasonic contrast agent |
01/09/2013 | CN102861344A Preparation of gold nanoparticle coated with folic acid-modified pegylated dendrimer |
01/09/2013 | CN102488904B Gastric mucosa targeting super-paramagnetic magnetic resonance contrast medium composition and preparation method thereof |
01/09/2013 | CN102068704B Dental plaque detection liquid |
01/09/2013 | CN101786601B Preparation method of compound nano particle with Fe3O4/CoO core shell structure |
01/09/2013 | CN101232905B Oral preparation useful in measuring capacity to metabolize pyridine |
01/08/2013 | US8349294 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
01/08/2013 | US8349292 Treatment of allergic otitis media in mammals with Clostridia neurotoxins |
01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
01/03/2013 | WO2013003507A1 Multifunctional agents |